Wang Y - Search Results

1

LAMC2 enhances the metastatic potential of lung adenocarcinoma.

Moon YW, Rao G, Kim JJ, Shim HS, Park KS, An SS, Kim B, Steeg PS, Sarfaraz S, Changwoo Lee L, Voeller D, Choi EY, Luo J, Palmieri D, Chung HC, Kim JH, Wang Y, Giaccone G. Moon YW, et al. Among authors: wang y. Cell Death Differ. 2015 Aug;22(8):1341-52. doi: 10.1038/cdd.2014.228. Epub 2015 Jan 16. Cell Death Differ. 2015. PMID: 25591736 Free PMC article.

2

Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells.

Kim IK, Rao G, Zhao X, Fan R, Avantaggiati ML, Wang Y, Zhang YW, Giaccone G. Kim IK, et al. Among authors: wang y. Cell Death Differ. 2020 Jul;27(7):2263-2279. doi: 10.1038/s41418-020-0502-7. Epub 2020 Feb 7. Cell Death Differ. 2020. PMID: 32034314 Free PMC article.

3

MicroRNA expression and clinical outcome of small cell lung cancer.

Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G. Lee JH, et al. Among authors: wang y. PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731696 Free PMC article.

4

CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.

An R, Wang Y, Voeller D, Gower A, Kim IK, Zhang YW, Giaccone G. An R, et al. Among authors: wang y. Oncotarget. 2016 May 17;7(20):29199-210. doi: 10.18632/oncotarget.8638. Oncotarget. 2016. PMID: 27078848 Free PMC article.

5

Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations.

Rao G, Pierobon M, Kim IK, Hsu WH, Deng J, Moon YW, Petricoin EF, Zhang YW, Wang Y, Giaccone G. Rao G, et al. Among authors: wang y. Sci Rep. 2017 Aug 1;7(1):7066. doi: 10.1038/s41598-017-06128-9. Sci Rep. 2017. PMID: 28765579 Free PMC article.

6

High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.

Park KS, Moon YW, Raffeld M, Lee DH, Wang Y, Giaccone G. Park KS, et al. Among authors: wang y. Lung Cancer. 2018 Feb;116:38-45. doi: 10.1016/j.lungcan.2017.12.010. Epub 2017 Dec 15. Lung Cancer. 2018. PMID: 29413049 Free PMC article.

7

Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors.

Giaccone G, Wang Y. Giaccone G, et al. Among authors: wang y. Cancer Treat Rev. 2011 Oct;37(6):456-64. doi: 10.1016/j.ctrv.2011.01.003. Epub 2011 Mar 1. Cancer Treat Rev. 2011. PMID: 21367530 Free PMC article. Review.

8

Challenges in cancer molecular targets and therapeutics.

Wang Y, Giaccone G. Wang Y, et al. Front Oncol. 2011 May 2;1:4. doi: 10.3389/fonc.2011.00004. eCollection 2011. Front Oncol. 2011. PMID: 22655226 Free PMC article. No abstract available.

9

Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.

Petrini I, Wang Y, Zucali PA, Lee HS, Pham T, Voeller D, Meltzer PS, Giaccone G. Petrini I, et al. Among authors: wang y. Clin Cancer Res. 2013 Apr 15;19(8):1960-71. doi: 10.1158/1078-0432.CCR-12-3260. Epub 2013 Feb 26. Clin Cancer Res. 2013. PMID: 23444221 Free PMC article. Clinical Trial.

10

Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.

Gower A, Wang Y, Giaccone G. Gower A, et al. Among authors: wang y. J Mol Med (Berl). 2014 Jul;92(7):697-707. doi: 10.1007/s00109-014-1165-y. Epub 2014 May 23. J Mol Med (Berl). 2014. PMID: 24852181 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273,719 results

Search Page